CL vs OGEN · P/E 34, rev $20.38B vs rev $37.7K
Colgate-Palmolive Company (CL) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CL and OGEN stock pages for the full models.
Not investment advice.